Stonepine Capital Management, LLC 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:34 pm Sale | 2023-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | Stonepine Capital Management, LLC | 5,937,000 4.300% | -5,258,189 (-46.97%) | Filing |
| 2023-02-13 10:57 am Purchase | 2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | Stonepine Capital Management, LLC | 11,195,189 8.200% | 4,704,090 (+72.47%) | Filing |
| 2022-01-13 6:13 pm Purchase | 2022-01-07 | 13G | Xeris Biopharma Holdings, Inc. XERS | Stonepine Capital Management, LLC | 6,491,099 5.200% | 6,491,099 (New Position) | Filing |